Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Morales

Showing results (161-170 of 186) with videos related to

Pageof 19
Sort By:
Journal of the International AIDS Society|November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsJosep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2009
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patientsEdwin Dejesus, Benjamin Young, Javier O Morales-Ramirez, et al.
Cureus|April 19, 2024
Integrating Pre-test Probability and Point-of-Care Ultrasound (POCUS) in the Emergency Department (ED) Diagnosis of Small Bowel Obstruction (SBO)Katarzyna Krol, Yi-Ru Chen, Melva O Morales Sierra, et al.
Biomolecules|December 23, 2023
Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ PolymorphismsSandra A Reza-López, Susana González-Gurrola, Oscar O Morales-Morales, et al.
Medical Education|May 7, 2010
Health-related quality of life of medical studentsHelena B M S Paro, Nívea M O Morales, Carlos H M Silva, et al.
Plant, Cell & Environment|March 14, 2020
The photoreceptor UVR8 mediates the perception of both UV-B and UV-A wavelengths up to 350 nm of sunlight with responsivity moderated by cryptochromesNeha Rai, Andrew O'Hara, Daniel Farkas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individualsMartin Markowitz, Javier O Morales-Ramirez, Bach-Yen Nguyen, et al.
The Lancet. Microbe|February 20, 2026
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 studyOnyema Ogbuagu, Aditya Gaur, James H McMahon, et al.
Revista De Gastroenterologia De Mexico (English)|November 12, 2025
Factors associated with mortality in women with decompensated alcohol-related cirrhosisJ L Pérez-Hernández, A D Santana-Vargas, G Gutiérrez-Reyes, et al.
Journal of Clinical Medicine|March 29, 2023
Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4-5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study)Sandra Valdivielso Moré, Miren Vicente Elcano, Anna García Alonso, et al.
Pageof 19

Showing results (161-170 of 186) with videos related to

Sort By:
Pageof 19
Journal of the International AIDS Society|November 14, 2014
Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsJosep M Gatell, Javier O Morales-Ramirez, Debbie P Hagins, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2009
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patientsEdwin Dejesus, Benjamin Young, Javier O Morales-Ramirez, et al.
Cureus|April 19, 2024
Integrating Pre-test Probability and Point-of-Care Ultrasound (POCUS) in the Emergency Department (ED) Diagnosis of Small Bowel Obstruction (SBO)Katarzyna Krol, Yi-Ru Chen, Melva O Morales Sierra, et al.
Biomolecules|December 23, 2023
Metabolic Biomarkers in Adults with Type 2 Diabetes: The Role of PPAR-γ2 and PPAR-β/δ PolymorphismsSandra A Reza-López, Susana González-Gurrola, Oscar O Morales-Morales, et al.
Medical Education|May 7, 2010
Health-related quality of life of medical studentsHelena B M S Paro, Nívea M O Morales, Carlos H M Silva, et al.
Plant, Cell & Environment|March 14, 2020
The photoreceptor UVR8 mediates the perception of both UV-B and UV-A wavelengths up to 350 nm of sunlight with responsivity moderated by cryptochromesNeha Rai, Andrew O'Hara, Daniel Farkas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 30, 2006
Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individualsMartin Markowitz, Javier O Morales-Ramirez, Bach-Yen Nguyen, et al.
The Lancet. Microbe|February 20, 2026
Efficacy and safety of lenacapavir, teropavimab, and zinlirvimab: week-26 primary outcome results from a multicentre, open-label, randomised, active-controlled, phase 2 studyOnyema Ogbuagu, Aditya Gaur, James H McMahon, et al.
Revista De Gastroenterologia De Mexico (English)|November 12, 2025
Factors associated with mortality in women with decompensated alcohol-related cirrhosisJ L Pérez-Hernández, A D Santana-Vargas, G Gutiérrez-Reyes, et al.
Journal of Clinical Medicine|March 29, 2023
Characteristics of Patients with Heart Failure and Advanced Chronic Kidney Disease (Stages 4-5) Not Undergoing Renal Replacement Therapy (ERCA-IC Study)Sandra Valdivielso Moré, Miren Vicente Elcano, Anna García Alonso, et al.
Pageof 19